.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Fuji
Cipla
Healthtrust
Dow
Daiichi Sankyo
Chinese Patent Office
Citi
Deloitte
Queensland Health

Generated: June 24, 2017

DrugPatentWatch Database Preview

Mexiletine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for mexiletine hydrochloride and what is the scope of mexiletine hydrochloride freedom to operate?

Mexiletine hydrochloride
is the generic ingredient in two branded drugs marketed by Watson Labs, Idt Australia Ltd, Boehringer Ingelheim, and Teva, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for mexiletine hydrochloride. Five suppliers are listed for this compound.

Summary for Generic Name: mexiletine hydrochloride

Tradenames:2
Patents:1
Applicants:4
NDAs:5
Drug Master File Entries: see list5
Suppliers / Packagers: see list5
Bulk Api Vendors: see list66
Clinical Trials: see list2,265
Patent Applications: see list1,221
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mexiletine hydrochloride at DailyMed

Pharmacology for Ingredient: mexiletine hydrochloride

Drug ClassAntiarrhythmic
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
MEXILETINE HYDROCHLORIDE
mexiletine hydrochloride
CAPSULE;ORAL074865-001Apr 13, 1998DISCNNoNo► Subscribe► Subscribe
Boehringer Ingelheim
MEXITIL
mexiletine hydrochloride
CAPSULE;ORAL018873-003Dec 30, 1985DISCNNoNo► Subscribe► Subscribe
Teva
MEXILETINE HYDROCHLORIDE
mexiletine hydrochloride
CAPSULE;ORAL074377-001May 16, 1995RXNoNo► Subscribe► Subscribe
Teva
MEXILETINE HYDROCHLORIDE
mexiletine hydrochloride
CAPSULE;ORAL074377-003May 16, 1995RXNoYes► Subscribe► Subscribe
Boehringer Ingelheim
MEXITIL
mexiletine hydrochloride
CAPSULE;ORAL018873-002Dec 30, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: mexiletine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim
MEXITIL
mexiletine hydrochloride
CAPSULE;ORAL018873-003Dec 30, 19854,031,244► Subscribe
Boehringer Ingelheim
MEXITIL
mexiletine hydrochloride
CAPSULE;ORAL018873-004Dec 30, 19854,031,244► Subscribe
Boehringer Ingelheim
MEXITIL
mexiletine hydrochloride
CAPSULE;ORAL018873-002Dec 30, 19853,954,872► Subscribe
Boehringer Ingelheim
MEXITIL
mexiletine hydrochloride
CAPSULE;ORAL018873-004Dec 30, 19853,954,872► Subscribe
Boehringer Ingelheim
MEXITIL
mexiletine hydrochloride
CAPSULE;ORAL018873-003Dec 30, 19853,954,872► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Citi
Johnson and Johnson
Cipla
Cantor Fitzgerald
AstraZeneca
Farmers Insurance
McKinsey
Medtronic
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot